| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Centre, Madrid, Spain; 2 Kirikkale University Faculty of Medicine, Kirikkale, Turkey; 3 Departamento de Bioquímica, Facultad de Medicina, Instituto de Investigaciones Biomédicas, Centro de Biologia Molecular "Severo Ochoa," Universidad Autonoma de Madrid, Madrid, Spain; 4 Centre Commun de Quantimetrie, Faculte de Medecine, Universite Claude Bernard Lyon I, Lyon, France; and 5 Cancer Research Institute, University of California at San Francisco, San Francisco, California
Whereas accepted models of tumorigenesis exist for genetic lesions, the timing of epigenetic alterations in cancer is not clearly understood. We have analyzed the profile of aberrations in DNA methylation occurring in cells lines and primary tumors of one of the best-characterized mouse carcinogenesis systems, the multistage skin cancer progression model. Initial analysis using high-performance capillary electrophoresis and immunolocalization revealed a loss of genomic 5-methylcytosine associated with the degree of tumor aggressiveness. Paradoxically, this occurs in the context of a growing number of hypermethylated CpG islands of tumor suppressor genes at the most malignant stages of carcinogenesis. We have observed this last phenomenon using two approaches, a candidate gene approach, studying genes with well-known methylation-associated silencing in human tumors, and a mouse cDNA microarray expression analysis after treatment with DNA demethylating drugs. The transition from epithelial to spindle cell morphology is particularly associated with major epigenetic alterations, such as E-cadherin methylation, demethylation of the Snail promoter, and a decrease of the global DNA methylation. Analysis of data obtained from the cDNA microarray strategy led to the identification of new genes that undergo methylation-associated silencing and have growth-inhibitory effects, such as the insulin-like growth factor binding protein-3. Most importantly, all of the above genes were also hypermethylated in human cancer cell lines and primary tumors, underlining the value of the mouse skin carcinogenesis model for the study of aberrant DNA methylation events in cancer cells.
This article has been cited by other articles:
|
|
 |
|
  C. Ausch, Y.-H. Kim, K. D. Tsuchiya, S. Dzieciatkowski, M. K. Washington, C. Paraskeva, J. Radich, and W. M. Grady Comparative Analysis of PCR-Based Biomarker Assay Methods for Colorectal Polyp Detection from Fecal DNA Clin. Chem., August 1, 2009; 55(8): 1559 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Agiostratidou, M. Li, K. Suyama, I. Badano, R. Keren, S. Chung, A. Anzovino, J. Hulit, B. Qian, B. Bouzahzah, et al. Loss of Retinal Cadherin Facilitates Mammary Tumor Progression and Metastasis Cancer Res., June 15, 2009; 69(12): 5030 - 5038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. R. Sobrado, G. Moreno-Bueno, E. Cubillo, L. J. Holt, M. A. Nieto, F. Portillo, and A. Cano The class I bHLH factors E2-2A and E2-2B regulate EMT J. Cell Sci., April 1, 2009; 122(7): 1014 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jiang, T. A. Gonda, M. V. Gamble, M. Salas, V. Seshan, S. Tu, W. S. Twaddell, P. Hegyi, G. Lazar, I. Steele, et al. Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts Cancer Res., December 1, 2008; 68(23): 9900 - 9908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Peinado, G. Moreno-Bueno, D. Hardisson, E. Perez-Gomez, V. Santos, M. Mendiola, J. I. de Diego, M. Nistal, M. Quintanilla, F. Portillo, et al. Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas Cancer Res., June 15, 2008; 68(12): 4541 - 4550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamashita, S. Takahashi, N. McDonell, N. Watanabe, T. Niwa, K. Hosoya, Y. Tsujino, T. Shirai, and T. Ushijima Methylation Silencing of Transforming Growth Factor-{beta} Receptor Type II in Rat Prostate Cancers Cancer Res., April 1, 2008; 68(7): 2112 - 2121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Esteller Epigenetics in Cancer N. Engl. J. Med., March 13, 2008; 358(11): 1148 - 1159. [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Newkirk, A. E. Parent, S. L. Fossey, C. Choi, H. L. Chandler, P. J. Rajala-Schultz, and D. F. Kusewitt Snai2 Expression Enhances Ultraviolet Radiation-Induced Skin Carcinogenesis Am. J. Pathol., November 1, 2007; 171(5): 1629 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Esteller Epigenetic gene silencing in cancer: the DNA hypermethylome Hum. Mol. Genet., April 15, 2007; 16(R1): R50 - R59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Morey, D. J. Smiraglia, S. R. James, J. Yu, M. T. Moser, B. A. Foster, and A. R. Karpf DNA Methylation Pathway Alterations in an Autochthonous Murine Model of Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11659 - 11667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Tirado, S. Mateo-Lozano, J. Villar, L. E. Dettin, A. Llort, S. Gallego, J. Ban, H. Kovar, and V. Notario Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells. Cancer Res., October 15, 2006; 66(20): 9937 - 9947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Cadieux, T.-T. Ching, S. R. VandenBerg, and J. F. Costello Genome-wide Hypomethylation in Human Glioblastomas Associated with Specific Copy Number Alteration, Methylenetetrahydrofolate Reductase Allele Status, and Increased Proliferation. Cancer Res., September 1, 2006; 66(17): 8469 - 8476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Martin-Oliva, R. Aguilar-Quesada, F. O'Valle, J. A. Munoz-Gamez, R. Martinez-Romero, R. Garcia del Moral, J. M. Ruiz de Almodovar, R. Villuendas, M. A. Piris, and F. J. Oliver Inhibition of Poly(ADP-Ribose) Polymerase Modulates Tumor-Related Gene Expression, Including Hypoxia-Inducible Factor-1 Activation, during Skin Carcinogenesis Cancer Res., June 1, 2006; 66(11): 5744 - 5756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Bachman, G. M. Curtin, D. J. Doolittle, and J. I. Goodman Altered Methylation in Gene-Specific and GC-Rich Regions of DNA Is Progressive and Nonrandom during Promotion of Skin Tumorigenesis Toxicol. Sci., June 1, 2006; 91(2): 406 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Pogribny, S. A. Ross, V. P. Tryndyak, M. Pogribna, L. A. Poirier, and T. V. Karpinets Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats Carcinogenesis, June 1, 2006; 27(6): 1180 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ibanez de Caceres, E. Dulaimi, A. M. Hoffman, T. Al-Saleem, R. G. Uzzo, and P. Cairns Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res., May 15, 2006; 66(10): 5021 - 5028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mulero-Navarro, J.M. Carvajal-Gonzalez, M. Herranz, E. Ballestar, M.F. Fraga, S. Ropero, M. Esteller, and P.M. Fernandez-Salguero The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding Carcinogenesis, May 1, 2006; 27(5): 1099 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M.E.I. Hellebrekers, K.-W. Jair, E. Vire, S. Eguchi, N. T.H. Hoebers, M. F. Fraga, M. Esteller, F. Fuks, S. B. Baylin, M. van Engeland, et al. Angiostatic activity of DNA methyltransferase inhibitors. Mol. Cancer Ther., February 1, 2006; 5(2): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Herranz, J. Martin-Caballero, M. F. Fraga, J. Ruiz-Cabello, J. M. Flores, M. Desco, V. Marquez, and M. Esteller The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma Blood, February 1, 2006; 107(3): 1174 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jang, J. B. Mason, and S.-W. Choi Genetic and Epigenetic Interactions between Folate and Aging in Carcinogenesis J. Nutr., December 1, 2005; 135(12): 2967S - 2971S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. O. Gure, R. Chua, B. Williamson, M. Gonen, C. A. Ferrera, S. Gnjatic, G. Ritter, A. J.G. Simpson, Y.-T. Chen, L. J. Old, et al. Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non-Small Cell Lung Cancer Clin. Cancer Res., November 15, 2005; 11(22): 8055 - 8062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vineis and K. Husgafvel-Pursiainen Air pollution and cancer: biomarker studies in human populations Carcinogenesis, November 1, 2005; 26(11): 1846 - 1855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. V. Karpinets and B. D. Foy Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations Carcinogenesis, August 1, 2005; 26(8): 1323 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Margulis, W. Zhang, A. Alt-Holland, H. C. Crawford, N. E. Fusenig, and J. A. Garlick E-cadherin Suppression Accelerates Squamous Cell Carcinoma Progression in Three-Dimensional, Human Tissue Constructs Cancer Res., March 1, 2005; 65(5): 1783 - 1791. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
